Source: Financial Times
Published: August 27 2007 03:00 | Last updated: August 27 2007 03:00
Summary:
Human embryonic stem cells can repair damaged hearts, according to new animal research. If the results are confirmed in clinical trials, heart disease may be a multibillion dollar market for stem cell therapies. Scientists at the University of Washington and Geron, the California-based biotechnology company, implanted cardiac cells derived from human embryonic stem cells into rats four days after a heart attack. They helped rebuild the animals’ heart muscles and improved the functioning of the whole heart.
